Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Hsd17b13em1/Cya
Common Name:
Hsd17b13-KO
Product ID:
S-KO-07421
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Hsd17b13-KO
Strain ID
KOCMP-243168-Hsd17b13-B6N-VA
Gene Name
Hsd17b13
Product ID
S-KO-07421
Gene Alias
PAN1B-like; Pan1b
Background
C57BL/6NCya
NCBI ID
243168
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:2140804
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Hsd17b13em1/Cya mice (Catalog S-KO-07421) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000048118
NCBI RefSeq
NM_198030
Target Region
Exon 2~6
Size of Effective Region
~6.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
HSD17B13, hydroxysteroid 17-β dehydrogenase family 13, is a liver-specific, lipid droplet-associated protein [3,5,8]. It has enzymatic pathways involving steroids, pro-inflammatory lipid mediators and retinol [8]. The 17β-Hydroxysteroid dehydrogenases (HSD17Bs) family, to which HSD17B13 belongs, is mainly involved in sex hormone metabolism, and some members also play roles in cholesterol and fatty acid metabolism [3]. Genetic models, such as gene knockout in mice, are valuable for studying its functions.

In mice, knockdown of Hsd17b13 protects against liver fibrosis in non-alcoholic steatohepatitis, associated with decreased pyrimidine catabolism at the level of dihydropyrimidine dehydrogenase [2]. Also, hepatic overexpression of HSD17B13 in mice promotes lipid accumulation in the liver [3]. The rs72613567-TA variant in HSD17B13, which leads to a loss-of-function, is associated with reduced risk of chronic liver diseases in humans and mitigates liver injury in mouse models [4]. Adeno-associated viral-mediated xeno-expression of human HSD17B13 exacerbates western diet/carbon tetrachloride-induced liver inflammation in Hsd17b13-/-mice [7].

In conclusion, HSD17B13 plays a role in hepatic lipid homeostasis and liver inflammation. Loss-of-function models, including gene knockout in mice, have revealed its contribution to the development of non-alcoholic fatty liver disease (NAFLD), liver fibrosis, and chronic liver inflammation. These findings suggest HSD17B13 could be a potential therapeutic target for treating related liver diseases [1,2,3,4,5,6,7,8,9].

References:

1. Zhang, Hai-Bo, Su, Wen, Xu, Hu, Zhang, Xiao-Yan, Guan, You-Fei. 2022. HSD17B13: A Potential Therapeutic Target for NAFLD. In Frontiers in molecular biosciences, 8, 824776. doi:10.3389/fmolb.2021.824776. https://pubmed.ncbi.nlm.nih.gov/35071330/

2. Luukkonen, Panu K, Sakuma, Ikki, Gaspar, Rafael C, Petersen, Kitt Falk, Shulman, Gerald I. 2023. Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2217543120. doi:10.1073/pnas.2217543120. https://pubmed.ncbi.nlm.nih.gov/36669104/

3. Su, Wen, Mao, Zhuo, Liu, Yiao, Gustafsson, Jan-Ake, Guan, Youfei. 2018. Role of HSD17B13 in the liver physiology and pathophysiology. In Molecular and cellular endocrinology, 489, 119-125. doi:10.1016/j.mce.2018.10.014. https://pubmed.ncbi.nlm.nih.gov/30365983/

4. Abul-Husn, Noura S, Cheng, Xiping, Li, Alexander H, Gromada, Jesper, Dewey, Frederick E. . A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease. In The New England journal of medicine, 378, 1096-1106. doi:10.1056/NEJMoa1712191. https://pubmed.ncbi.nlm.nih.gov/29562163/

5. Motomura, Takashi, Amirneni, Sriram, Diaz-Aragon, Ricardo, Florentino, Rodrigo M, Soto-Gutierrez, Alejandro. 2021. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. In Journal of personalized medicine, 11, . doi:10.3390/jpm11070619. https://pubmed.ncbi.nlm.nih.gov/34208839/

6. Wang, P, Wu, C-X, Li, Y, Shen, N. . HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis. In European review for medical and pharmacological sciences, 24, 8997-9007. doi:10.26355/eurrev_202009_22842. https://pubmed.ncbi.nlm.nih.gov/32964989/

7. Ye, Jing, Huang, Xiyu, Yuan, Manman, Xu, Qiang, Wu, Xingxin. . HSD17B13 liquid-liquid phase separation promotes leukocyte adhesion in chronic liver inflammation. In Journal of molecular cell biology, 16, . doi:10.1093/jmcb/mjae018. https://pubmed.ncbi.nlm.nih.gov/38692847/

8. Amangurbanova, Maral, Huang, Daniel Q, Loomba, Rohit. 2022. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD. In Alimentary pharmacology & therapeutics, 57, 37-51. doi:10.1111/apt.17292. https://pubmed.ncbi.nlm.nih.gov/36349732/

9. Stender, Stefan, Romeo, Stefano. . HSD17B13 as a promising therapeutic target against chronic liver disease. In Liver international : official journal of the International Association for the Study of the Liver, 40, 756-757. doi:10.1111/liv.14411. https://pubmed.ncbi.nlm.nih.gov/32255570/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest